nonalcoholic fatty liver disease (NAFLD) represents a spectrum of disorders characterized by predominantly macrovesicular hepatic steatosis that occur in individuals even in the absence of consumption of alcohol in amounts considered harmful to the liver. NAFLD is being increasingly recognized as a major cause of liver related morbidity and mortality. The likelihood of having NAFLD is directly proportional to body weight. Given the increasing prevalence of obesity in North America, NAFLD is an important public health problem. These considerations have led to the development of the technical review and practice guidelines statement, which are sponsored by the American Gastroenterological Association (AGA) and the American Association for the Study of Liver Diseases (AASLD).
美国胃肠病学会医学立场声明：非酒精性脂肪性肝病（2002年）
发布日期：2002-11-01
英文标题：American Gastroenterological Association Medical Position Statement: Nonalcoholic Fatty Liver Disease
来源：Gastroenterology, 2002, 123(5): 1702-1704
阅读次数：815
